Latest News - Syneron

Wednesday, March 13, 2019

Study: Port Wine Stain Laser Treatment Is Safe and Effective in Infants Without Anesthesia

Recent concerns about the repetitive use of general anesthesia in children younger than 3 have placed greater importance on the controversy surrounding the timing of port-wine stain laser treatme…

Read the full story

Saturday, March 02, 2019

Candela Unveils New Corporate Identity at the 2019 AAD Annual Meeting

Syneron-Candela has rebranded the company to Candela and unveiled its new corporate branding at the American Academy of Dermatology (AAD) Annual Meeting. The new corporate identity reflects the unific…

Read the full story

Wednesday, September 26, 2018

Candela and Vascular Birthmark Foundation Offer Pro Bono Laser Treatments for Patients in Need

Candela Corporation is partnering with the Vascular Birthmarks Foundation (VBF) to provide pro-bono Vbeam laser treatments to children and adults with birthmarks, port wine stains and other vascular r…

Read the full story

Wednesday, September 12, 2018

New Laser Handpiece Clears Multicolor Tattoos in Fewer Treatments

A new titanium sapphire laser handpiece can clear green, blue, and purple tattoo pigments in fewer treatments, according to a new study in Lasers in Surgery and Medicine (LSM). Researchers led by A…

Read the full story

Tuesday, September 11, 2018

Business News: Candela Acquires Ellipse

Candela Corporation has acquired Ellipse, a Danish medical device company that manufactures and markets Intense Pulsed Light (IPL) and laser-based platforms for a wide variety of medical and aesthetic…

Read the full story

Wednesday, October 25, 2017

Use of a New Holographic Hand Piece May Improve Picosecond Laser Treatment of Acne Scars

Incorporating a new holographic beam splitter in a picosecond laser may help improve the appearance of acne scars, according to a study published in Lasers in Surgery and Medicine (LSM). The paper …

Read the full story

Monday, July 17, 2017

Syneron Candela Completes Transaction with Funds Advised by Apax Partners; Becomes a Private Company

Syneron Medical Ltd. announced the successful completion of its acquisition by an affiliate of funds advised by Apax Partners for $11.00 per share in cash in a transaction valued at approximately $400…

Read the full story

Monday, April 03, 2017

Apax Partners To Acquire Syneron for Close to $400 million

An affiliate of funds advised by Apax Partners will acquire all of the outstanding shares of Syneron Candela for $11.00 per share in cash in a transaction valued at approximately $397 m…

Read the full story

Tuesday, February 14, 2017

Rumor Has It Syneron Is Next In Week of Surprising Aquisitions

Hot off the heels of Allergan’s acquisition of Zeltiq and Hologic Inc,’s surprising purchase of Cynosure Inc., media reports are now swirling that British private equity fund Apax Partners…

Read the full story

Tuesday, November 08, 2016

FDA Clears Syneron Candela's Profound SubQ to Improve Cellulite

Syneron Candela  received FDA 510(k) clearance for Profound when using the SubQ handpiece and cartridge to improve the appearance of cellulite in patients with Fitzpatrick skin types I-III, as su…

Read the full story

Wednesday, August 10, 2016

Men, New Technologies Drive Growth in Body Contouring Market

The body contouring market is set to rise from $671.8 million in 2015 to more than $1.1 billion by 2022, representing a compound annual growth rate of 7.9%, according to research and consulting firm G…

Read the full story

Monday, July 25, 2016

Syneron Candela's PicoWay Picosecond Laser Receives U.S. FDA Clearance for Ultra-Short 785nm Wavelength

And then there were three. The U.S. Food and Drug Administration (FDA) has cleared Syneron Medical Ltd.’s PicoWay® picosecond laser for a new ultra-short 785nm wavelength. The add…

Read the full story

Monday, July 18, 2016

FDA Clears Syneron Candela's UltraShape Power for Fat Destruction

The FDA cleared Syneron Medical Ltd.'s non-invasive fat destruction device, UltraShape Power. for non-invasive reduction of abdominal circumference via fat cell destruction. UltraShape Power us…

Read the full story

Tuesday, March 29, 2016

North America's Scar Treatment Poised for Growth Spurt by 2022

Scar treatment will be a hot growth area in coming years, according to a new report by Persistence Market Research. The report cites a rising incidence of burn and trauma cases and an increasi…

Read the full story

Sunday, March 06, 2016

APP® Membership Now Has More Rewards: Three Syneron Candela Platforms

Syneron Medical Ltd. and Allergan plc are joining forces to offer three of Syneron Candela's body sculpting and skincare platforms to members of Allergan Partner Privileges® (APP®). …

Read the full story
Load More